Taylor Wealth Management Partners Profound Medical Corp. Transaction History

Taylor Wealth Management Partners

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$6.34 - $9.53 $680,795 - $1.02 Million	-107,381 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$8.16 - $11.33 $195,268 - $271,126	-23,930 Reduced 18.22%	107,381 $966,000
Q4 2021 Jan 28, 2022	SELL	$10.38 - $15.2 $340,515 - $498,636	-32,805 Reduced 19.99%	131,311 $1.48 Million
Q3 2021 Oct 26, 2021	SELL	$13.6 - $17.88 $29,988 - $39,425	-2,205 Reduced 1.33%	164,116 $2.4 Million
Q2 2021 Aug 11, 2021	BUY	$16.0 - $20.59 $23,360 - $30,061	1,460 Added 0.89%	166,321 $2.72 Million

Q1 2021 Apr 21, 2021	SELL	$19.16 - $28.09 $27,456 - $40,252	-1,433 Reduced 0.86%	164,861 $3.32 Million
Q4 2020 Feb 02, 2021	SELL	$16.4 - $22.9 $1,148 - $1,603	-70 Reduced 0.04%	166,294 $3.42 Million
Q3 2020 Oct 14, 2020	BUY	$14.05 - $18.13 $757,814 - $977,877	53,937 Added 47.98%	166,364 $2.94 Million
Q2 2020 Jul 27, 2020	SELL	$9.41 - $16.94 $63,348 - $114,040	-6,732 Reduced 5.65%	112,427 $1.91 Million
Q1 2020 May 04, 2020	BUY	$6.88 - $19.7 $819,813 - $2.35 Million	119,159 New	119,159 $1.16 Million

8.97M

34.3K

2.8K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $186M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Taylor Wealth Management Partners, based on Form 13F filings with the SEC.

Stay updated on Taylor Wealth Management Partners with notifications on news.